Clinical Trials
11
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)โข Click on a phase to view related trials
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
- Conditions
- Myopia
- First Posted Date
- 2024-11-22
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Vance Thompson Vision
- Target Recruit Count
- 56
- Registration Number
- NCT06700460
- Locations
- ๐บ๐ธ
Kugler Vision, Omaha, Nebraska, United States
๐บ๐ธCleveland Eye Clinic, Cleveland, Ohio, United States
๐บ๐ธCarolina Eyecare Physicians, Mt. Pleasant, South Carolina, United States
Clinical Outcomes of Patients Implanted With the RxSight Light Adjustable Lens (LAL)
- Conditions
- CataractPseudophakia
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Vance Thompson Vision
- Registration Number
- NCT06488066
- Locations
- ๐บ๐ธ
Vance Thompson Vision, Sioux Falls, South Dakota, United States
Evaluate the TetraLens, a Tetracaine Releasing Therapeutic Bandage Contact Lens in Patients Undergoing PRK Procedure
- Conditions
- Ocular Pain
- Interventions
- Drug: TetraLens bandage contact lensDevice: Control Acuvue Oasys Bandage contact Lens
- First Posted Date
- 2023-10-16
- Last Posted Date
- 2024-05-20
- Lead Sponsor
- Vance Thompson Vision
- Target Recruit Count
- 10
- Registration Number
- NCT06085352
- Locations
- ๐บ๐ธ
Vance Thompson Vision, Sioux Falls, South Dakota, United States
A Randomized, Double-Masked, Controlled, Single Site Investigator Initiated, Exploratory Study of the Midazolam/Ketamine Melt vs Ketamine Melt Alone vs Midazolam Melt Alone in Subjects Undergoing Intraocular Surgery.
- Conditions
- Anesthesia
- Interventions
- Drug: Midazolam/Ketamine HCl 3mg-50mg sublingual
- First Posted Date
- 2021-01-27
- Last Posted Date
- 2021-01-27
- Lead Sponsor
- Vance Thompson Vision
- Target Recruit Count
- 50
- Registration Number
- NCT04725747
- Locations
- ๐บ๐ธ
Vance Thompson Vision, Sioux Falls, South Dakota, United States
Vivity Outcomes in Patients With Early Stage Glaucoma
- Conditions
- GlaucomaPresbyopiaCataract
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2024-05-20
- Lead Sponsor
- Vance Thompson Vision
- Target Recruit Count
- 27
- Registration Number
- NCT04670575
- Locations
- ๐บ๐ธ
Vance Thompson Vision, Sioux Falls, South Dakota, United States
- Prev
- 1
- 2
- 3
- Next
News
Travoprost Clinical Trials Show Promise, Uveitis Incidence Data Presented, and Gel Anesthesia for Injections
Dr. John Berdahl of Vance Thompson Vision discussed the promising clinical trial results of travoprost, offering new insights into its efficacy.